|
|
Clinical value of D-dimer and coagulation indexes in pregnant women with gestational hypertension |
WU Li-xia CHEN Shu-zhu▲ |
Department of Laboratory Medicine, Putian Hanjiang Hospital |
|
|
Abstract Objective To investigate the clinical value of D-dimer (D-D) and coagulation indexes in pregnant women with hypertension during pregnancy.Methods A total of 68 pregnant women with gestational hypertension admitted to Putian Hanjiang Hospital from January 2018 to December 2020 were selected as the observation group, including 22 cases with simple gestational hypertension, 29 cases with mild preeclampsia (PE), and 17 cases with severe PE.Sixtyeight normal pregnant women were selected as the control group.D-D and coagulation indexes (activated partial thromboplastin time [APTT], prothrombin time [PT], thrombin time [TT]) of pregnant women and pregnant women with different severity of gestational hypertension were compared between the two groups.The correlation between D-D, coagulation indexes and the severity of gestational hypertension was analyzed.Results The D-D level in the observation group was higher than that in the control group, and the APTT, PT and TT were shorter than those in the control group, the differences were statistically significant (P<0.05).The level of D-D in severe PE group was higher than that in mild PE group and simple gestational hypertension group, the levels of APTT, PT and TT were shorter than those of mild PE group and simple gestational hypertension group, the differences were statistically significant (P<0.05).The levels of DD in mild PE group were higher than those in simple gestational hypertension group, while the levels of APTT, PT and TT were shorter than those in simple gestational hypertension group, the differences were statistically significant (P<0.05).D-D was positively correlated with the severity of gestational hypertension, while APTT, PT, TT were negatively correlated with the severity of gestational hypertension (P<0.05).Conclusion D-D in pregnant women with hypertension during pregnancy is significantly increased, APTT, PT, and TT are significantly reduced.As the severity of the disease increases, D-D tends to increase, and APTT, PT, and TT tend to decrease, which can be used as new ideas for the treatment of hypertension during pregnancy
|
|
|
|
|
[1] |
郭凯敏,林淑君,许可,等.妊娠20 周前血清指标对妊娠期高血压疾病发生的预测意义[J].热带医学杂志,2018,18(6):783-786.
|
[2] |
赵一梅,刘海燕,刘莹莹,等.妊娠高血压患者血浆D-二聚体,凝血指标表达水平及临床意义[J].临床军医杂志,2019,47(8):875-876.
|
[3] |
秦秀云,贾晶.妊娠期高血压疾病患者凝血功能指标、血栓前状态指标水平变化及意义[J].山东医药,2018,58(21):72-74.
|
[4] |
王飞.妊娠期高血压孕妇血中α1-MG、CRP、D-D 变化的临床意义[J].中国计划生育学杂志,2018,26(4):283-285.
|
[5] |
吴春,符虹.凝血功能检测对妊娠期高血压孕妇的临床价值研究[J].中国生育健康杂志,2018,29(4):360-361,372.
|
[6] |
郭彩娇,杨红玲,高飞,等.孕20 周前妊娠期高血压孕妇常规检验指标的新临床意义研究[J].现代检验医学杂志,2018,33(1):95-98.
|
[7] |
中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2015)[J].中华围产医学杂志,2016,19(3):161-169.
|
[8] |
孙艳华.妊娠高血压疾病患者血液流变学凝血和纤溶系统指标检测的临床意义[J].河北医学,2018,24(9):1557-1561.
|
[9] |
郭冰杰,杨彩梅.血浆中D-dimer 在正常妊娠及妊娠高血压疾病孕妇中的表达差异[J].中国实验诊断学,2020,24(1):48-51.
|
[10] |
林淑娟.妊娠期高血压患者孕期血压控制及妊娠结局分析[J].中国医药科学,2020,10(6):100-103.
|
[11] |
张宁宁.不同程度妊娠期高血压孕妇的孕期血压控制和维持水平对分娩结局的影响研究[J].中国现代医生,2019,57(15):52-55.
|
[12] |
沈涌海,王智毅,陈忠宝.杭州地区不同孕期孕妇凝血功能、D-二聚体水平回顾分析[J].中国卫生检验杂志,2019,29(5):583-585.
|
[13] |
梁骑,邓健康,郭晓兰,等.妊娠不同时期孕妇血浆凝血四项、FDP、D-二聚体和AT-Ⅲ的变化及临床意义[J].中国临床研究,2019,32(1):75-77.
|
[14] |
柳直英.妊娠高血压疾病孕妇围生期凝血系统指标及血小板活化状态的变化探究[J].中国药物与临床,2019,19(5):793-795.
|
[15] |
王志强,赵波,邓耀,等.血液流变学及凝血指标对妊娠期高血压患者围产结局的影响[J].西部医学,2019,31(11):1715-1718.
|
[16] |
史艳春.孕妇妊娠不同时期凝血功能四项、D-二聚体、FDP 指标检测的临床意义[J].川北医学院学报,2018,33(1):114-117.
|
[17] |
郑少娟,李亮.凝血指标测定对妊娠期高血压疾病诊断与鉴别诊断的应用效果分析[J].中国计划生育和妇产科,2018,10(10):43-46.
|
|
|
|